The Plasma Therapy Market is gaining increasing attention within the global healthcare sector due to its expanding therapeutic applications and growing demand for advanced biologic treatments. Plasma therapy involves the use of plasma-derived components, including immunoglobulins, clotting factors, and albumin, to treat a wide range of medical conditions such as immune deficiencies, neurological disorders, bleeding disorders, and trauma-related complications. The rising prevalence of chronic and rare diseases, coupled with advancements in plasma fractionation technologies, is shaping the market’s growth trajectory.

Market Size and Growth Overview

Market Size 2024 – USD 436.32 million.
Market Size 2025 – USD 493.96 million.
Market Size 2033 – USD 1,332.81 million.
CAGR (2025–2033) – 13.21%.

The strong growth rate highlights the increasing clinical adoption of plasma therapies and expanding treatment indications across global healthcare systems.

Get Your Sample Report Here: https://straitsresearch.com/report/plasma-therapy-market/request-sample

Buy Report Now: https://straitsresearch.com/buy-now/plasma-therapy-market

Download full report https://straitsresearch.com/buy-now/plasma-therapy-market

Market Drivers

Rising Prevalence of Chronic and Rare Diseases

The increasing incidence of autoimmune disorders, immunodeficiency diseases, hemophilia, and neurological conditions is a major driver of the plasma therapy market. Plasma-derived products play a critical role in managing these conditions, supporting consistent market demand.

Growing Geriatric Population

The aging global population is more susceptible to chronic illnesses and immune-related disorders. This demographic trend significantly contributes to the rising demand for plasma-based therapies, particularly immunoglobulin treatments.

Advancements in Plasma Collection and Fractionation

Technological improvements in plasma collection, storage, and fractionation processes have enhanced product safety, yield, and efficiency. These advancements enable manufacturers to meet growing demand while maintaining stringent quality standards.

Expanding Clinical Applications

Plasma therapy is increasingly used in trauma care, critical care, and emergency medicine. Its role in managing severe infections, burns, and surgical complications further supports market growth.

Market Challenges

Limited Availability of Plasma Donations

The plasma therapy market is highly dependent on plasma donations. Limited donor availability and variability in donation rates across regions can constrain supply and impact market growth.

High Cost of Plasma-Derived Therapies

Plasma therapies involve complex manufacturing processes, leading to high treatment costs. These costs can limit accessibility, particularly in low- and middle-income regions.

Stringent Regulatory Requirements

Plasma-derived products are subject to strict regulatory oversight to ensure safety and efficacy. Compliance with regulatory standards can increase production costs and extend approval timelines.

Market Segmentation Analysis

By Product Type

The market is segmented into immunoglobulins, albumin, coagulation factors, and other plasma-derived products. Immunoglobulins hold a significant market share due to their widespread use in treating immune deficiencies and autoimmune disorders. Coagulation factors are essential for managing bleeding disorders, while albumin is commonly used in critical care and surgical procedures.

By Application

Neurology represents a major application segment, driven by the use of plasma therapies in treating conditions such as chronic inflammatory demyelinating polyneuropathy. Immunology applications are growing steadily due to rising immune-related disorders. Hematology and critical care applications also contribute significantly to market demand.

By End User

Hospitals dominate the market as the primary end users of plasma therapies, supported by advanced infrastructure and specialized medical expertise. Specialty clinics and ambulatory care centers are emerging as important segments, particularly for outpatient plasma treatments.

By Distribution Channel

Direct distribution to hospitals and healthcare facilities accounts for a major share, supported by long-term supply agreements. Plasma therapy products are also distributed through specialized healthcare distributors to ensure timely availability.

Competitive Landscape and Top Players Analysis

The plasma therapy market is moderately competitive, with key players focusing on capacity expansion, technological innovation, and strategic collaborations. Based on Straits Research insights, major companies operating in the market include:

1. CSL Limited – A global leader in plasma-derived therapies with extensive plasma collection and manufacturing capabilities.

2. Takeda Pharmaceutical Company Limited – Offers a broad portfolio of plasma-derived products for rare and chronic diseases.

3. Grifols, S.A. – Specializes in plasma collection, fractionation, and development of plasma-based therapies.

4. Octapharma AG – Focuses on high-quality plasma-derived products for hematology and immunology.

5. Kedrion Biopharma Inc. – Develops plasma-derived therapies for rare diseases and critical care.

6. LFB Group – Provides plasma-based medicinal products with a strong focus on immunology and critical care.

7. Bio Products Laboratory Ltd. – Supplies plasma-derived therapies primarily for national healthcare systems.

8. Kamada Ltd. – Develops specialized plasma-derived protein therapeutics.

9. ADMA Biologics, Inc. – Focuses on immunoglobulin products derived from human plasma.

10. China Biologic Products Holdings, Inc. – Operates plasma collection and manufacturing facilities serving regional markets.

Conclusion

The global plasma therapy market is poised for significant growth over the forecast period, driven by rising disease prevalence, technological advancements, and expanding clinical applications. While challenges such as limited plasma supply and high treatment costs persist, increasing investment in plasma collection infrastructure and product innovation is expected to support long-term market expansion. The market’s strong CAGR underscores its growing importance in modern healthcare.

About Us

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers